MITRA — Mithra Pharmaceuticals SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Mithra: Conversion of Portion Of Loans From Highbridge, Whitebox
Brief: Mithra Pharmaceuticals: Adjustment To Rights Of Holders Of Convertible Bonds
Mithra Pharmaceuticals jumps on Haloette FDA approval
Brief: Mithra: Nextstellis Oral Contraceptive Now Available In Australia
Brief: Mithra Appoints Christian Moretti As Chairman
Brief: Mithra Pharmaceuticals Completes Private Placement For EUR 23.5 Mln
Europe Research Roundup: About You Holding SE, Fortum Oyj, Pearson
Mithra Pharmaceutical rises as private placement reassures investors
Brief: Mithra Pharmaceuticals Announces Details Of EUR 23.5 Mln Private Placement
Brief: Mithra Pharmaceuticals Announces Intention To Proceed With Private Placement
Brief: Mithra Announces Resignation Of François Fornieri As Non-Executive Director
Brief: Mithra Pharmaceuticals Says Goldman Sachs Exercised Last Call Option For Outstanding EUR 5 Million Drawdown
Brief: Mithra Issues A Put Option Notice Under Capital Agreement With LDA Capital
Brief: Mithra Pharmaceuticals: Presentation Of Donesta® Phase 3 Topline Efficacy Results At 20Th ISGE World Congress
Brief: Mithra CDMO Announces Collaboration With MedinCell For Development Of Injectable Products For Malaria And Transplant Rejection
Brief: Mithra Announces Improved Consolidated Topline Results From Donesta Phase 3 Studies
Revenue miss, potential study delays weigh on Mithra's shares
Brief: Mithra FY Net Loss Widens To 116.9 Million Euros, Evaluates Risks For Estelle Launch In Russia Expected For H2 2022
Brief: Mithra Pharma - Mithra And Searchlight Pharma Announce Launch Of Haloette In Canada